December, 1995 (8)

• Expression of recombinant human Met-ase-1: a NK cell-specific granzyme.
  Smyth MJ, O'Connor MD, Kelly JM, Ganesvaran P, Thia KY, Trapani JA
  Biochem Biophys Res Commun. 1995 Dec; 217(2):675-683
• Recombinant soluble Fc gamma RII inhibits immune complex precipitation.
  Gavin AL, Wines BD, Powell MS, Hogarth PM
  Clin Exp Immunol. 1995 Dec; 102(3):620-625
• Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection.
  Crowe SM
  Aust N Z J Med. 1995 Dec; 25(6):777-783
• Fetal pig xenografts in NOD/Lt mice: lack of expression of Gal(alpha 1-3)Gal on endocrine cells and the effect of peritransplant anti-CD4 monoclonal antibody and graft immunomodification on graft survival.
  Koulmanda M, McKenzie I, Sandrin M, Mandel T
  Transplant Proc. 1995 Dec; 27(6):3570
• Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis.
  Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohney S, Rollins SA, Guilmette ER, Setter E, Squinto SP, McKenzie IF
  Nat Med. 1995 Dec; 1(12):1261-1267
• Cytotoxic lymphocyte-mediated immunotherapy.
  Smyth MJ, Kershaw MH
  Aust N Z J Med. 1995 Dec; 25(6):852-858
• CTL in mice immunized with human mucin 1 are MHC-restricted.
  Apostolopoulos V, Loveland BE, Pietersz GA, McKenzie IF
  J Immunol. 1995 Dec; 155(11):5089-5094
• Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B.
  Trapani JA
  Aust N Z J Med. 1995 Dec; 25(6):793-799

November, 1995 (3)

• Cholera deaths in Goma.
  Roberts L, Toole MJ
  Lancet. 1995 Nov; 346(8987):1431
• Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
  Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J
  Science. 1995 Nov; 270(5238):988-991
• Expression of recombinant soluble Fc epsilon RI: function and tissue distribution studies.
  Gavin AL, Snider J, Hulett MD, Mckenzie IF, Hogarth PM
  Immunology. 1995 Nov; 86(3):392-398

October, 1995 (2)

• Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.
  Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF
  Proc Natl Acad Sci U S A. 1995 Oct; 92(22):10128-10132
• Evolution of complex disasters.
  Burkholder BT, Toole MJ
  Lancet. 1995 Oct; 346(8981):1012-1015

September, 1995 (6)

• Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1.
  Tachedjian G, Hooker DJ, Gurusinghe AD, Bazmi H, Deacon NJ, Mellors J, Birch C, Mills J
  Virology. 1995 Sep; 212(1):58-68
• Multiple regions of human Fc gamma RII (CD32) contribute to the binding of IgG.
  Hulett MD, Witort E, Brinkworth RI, McKenzie IF, Hogarth PM
  J Biol Chem. 1995 Sep; 270(36):21188-21194
• The interferon-inducible autoantigen, IFI 16: localization to the nucleolus and identification of a DNA-binding domain.
  Dawson MJ, Trapani JA
  Biochem Biophys Res Commun. 1995 Sep; 214(1):152-162
• Anti-peptide monoclonal antibodies to intestinal mucin 3.
  Apostolopoulos V, Xing PX, McKenzie IF
  J Gastroenterol Hepatol. 1995 Sep; 10(5):555-561
• Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.
  Peak A, Rana S, Maharjan SH, Jolley D, Crofts N
  AIDS. 1995 Sep; 9(9):1067-1070
• Hepatic portal infiltrates in mice immunized with syngeneic lymphoid cells: connotations for models of autoimmune liver disease.
  Karanikas V, MacKay IR, Rowley MJ, Veitch B, Loveland BE
  J Gastroenterol Hepatol. 1995 Sep; 10(5):491-497

August, 1995 (5)

• The peptide loop consisting of amino acids 139-157 of human granzyme B (fragmentin 2) contains an immunodominant epitope recognized by the mouse.
  Apostolidis VA, Browne KA, Smyth MJ, Trapani JA
  Mol Immunol. 1995 Aug; 32(12):909-917
• Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies.
  D'Souza MP, Milman G, Bradac JA, McPhee D, Hanson CV, Hendry RM
  AIDS. 1995 Aug; 9(8):867-874
• Hepatitis B vaccination.
  Forsyth JR, Darlington R, Thompson S
  S Afr Med J. 1995 Aug; 85(8):793-794
• Tissue expression, structure and function of the murine Ly-6 family of molecules.
  Gumley TP, McKenzie IF, Sandrin MS
  Immunol Cell Biol. 1995 Aug; 73(4):277-296
• Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis.
  Shaw T, Locarnini SA
  Liver. 1995 Aug; 15(4):169-184

July, 1995 (8)

• Ascertaining exposure categories of HIV-infected individuals with previously unrecorded risk data.
  Stevenson EM, Thompson SC, Crofts N
  Med J Aust. 1995 Jul; 163(2):66-69
• A history of peer-based drug-user groups in Australia.
  Crofts N, Herkt D
  J Drug Iss. 1995 Jul; 25(3):599-616
• Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
  Gurusinghe AD, Land SA, Birch C, McGavin C, Hooker DJ, Tachedjian G, Doherty R, Deacon NJ
  J Med Virol. 1995 Jul; 46(3):238-243
• Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro.
  McMillan JS, Shaw T, Angus PW, Locarnini SA
  Hepatology. 1995 Jul; 22(1):36-43
• Immunotherapy and immunoprophylaxis of respiratory syncytial virus infections
  Mills J
  Curr Opin Infect Dis. 1995 Jul; 8(6):473-478
• Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression.
  Sonza S, Maerz A, Uren S, Violo A, Hunter S, Boyle W, Crowe S
  AIDS Res Hum Retroviruses. 1995 Jul; 11(7):769-776
• In vitro and in vivo antitumor activity of a chimeric anti-CD19 antibody.
  Pietersz GA, Wenjun L, Sutton VR, Burgess J, McKenzie IF, Zola H, Trapani JA
  Cancer Immunol Immunother. 1995 Jul; 41(1):53-60
• Cloning and characterization of a novel NK cell-specific serine protease gene and its functional 5'-flanking sequences.
  Smyth MJ, Hulett MD, Thia KY, Young HA, Sayers TJ, Carter CR, Trapani JA
  Immunogenetics. 1995 Jul; 42(2):101-111

June, 1995 (7)

• Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I.
  Smyth MJ, McGuire MJ, Thia KY
  J Immunol. 1995 Jun; 154(12):6299-6305
• HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii.
  Biggs BA, Hewish M, Kent S, Hayes K, Crowe SM
  J Immunol. 1995 Jun; 154(11):6132-6139
• Determinants of HIV risk among men who have homosexual sex and inject drugs.
  Crofts N, Marcus L, Meade J, Sattler G, Wallace J, Sharp R
  AIDS Care. 1995 Jun; 7(5):647-655
• Infiltrating cells in mouse cardiac allografts after anti-CD4 monoclonal antibody treatment.
  Han WR, Mottram PL, Purcell LJ, Plenter RJ, McKenzie IF
  Transplant Proc. 1995 Jun; 27(3):2163
• The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes.
  Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, Locarnini S
  J Virol. 1995 Jun; 69(6):3350-3357
• Construction of CD46 minigenes for the production of transgenic mice.
  Thorley BR, McInnes B, Christiansen D, McKenzie IF, Loveland BE
  Transplant Proc. 1995 Jun; 27(3):2177-2178
• Phase-I study of synthetic muc1 peptides in breast-cancer.
  Xing P, Michael M, Apostolopoulos V, Prenzoska J, Marshall C, Bishop J, McKenzie I
  Int J Oncol. 1995 Jun; 6(6):1283-1289

May, 1995 (2)

• The kinetics of surface expression of CD11/CD18 integrins and CD54 on monocytes and macrophages.
  Stent G, Irving L, Lewin S, Crowe SM
  Clin Exp Immunol. 1995 May; 100(2):366-376
• Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir.
  Dean J, Bowden S, Locarnini S
  Antiviral Res. 1995 May; 27(1-2):171-178

April, 1995 (4)

• Expression of MUC2 gene product in mucinous carcinoma of the breast - Comparison with invasive ductal carcinoma.
  Yonezawa S, Nomoto M, Matsukita S, Xing PX, Mckenzie IFC, Hilkens J, Kim YS, Sato E
  Acta Histochem Cytochem. 1995 Apr; 28(3):239-246
• The role of bronchoscopy in the diagnosis and treatment of pulmonary disease in HIV-infected patients.
  Lewin SR, Hoy J, Crowe SM, McDonald CF
  Aust N Z J Med. 1995 Apr; 25(2):133-139
• Sequence and structure of the mouse ThB gene.
  Gumley TP, McKenzie IF, Sandrin MS
  Immunogenetics. 1995 Apr; 42(3):221-224
• Granzymes: exogenous proteinases that induce target cell apoptosis.
  Smyth MJ, Trapani JA
  Immunol Today. 1995 Apr; 16(4):202-206

March, 1995 (5)

• The immunogenicity of MUC1 peptides and fusion protein.
  Apostolopoulos V, Pietersz GA, Xing PX, Lees CJ, Michael M, Bishop J, McKenzie IF
  Cancer Lett. 1995 Mar; 90(1):21-26
• Locally acquired hepatitis E in the Northern Territory of Australia.
  Heath TC, Burrow JN, Currie BJ, Bowden FJ, Fisher DA, Demediuk BH, Locarnini SA, Anderson DA.
  Med J Aust. 1995 Mar; 162(6):318-319
• Understanding gender differences in psychological functioning and treatment retention.
  Wodak A, Capelhorn J, Crofts N
  Am J Drug Alcohol Abuse. 1995 Mar; 21(2):283-284
• Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines.
  Greenway A, Azad A, McPhee D
  J Virol. 1995 Mar; 69(3):1842-1850
• Seroepidemiology of hepatitis E in selected Australian populations.
  Moaven L, Van Asten M, Crofts N, Locarnini SA
  J Med Virol. 1995 Mar; 45(3):326-330

February, 1995 (11)

• Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
  Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW
  Transplantation. 1995 Feb; 59(4):559-565
• False-negative results for HIV-1.
  Anderson JS, Locarnini SA, Doherty RR, Breschkin AM, Dax EM, Mijch AM
  Med J Aust. 1995 Feb; 162(4):220
• Spread of bloodborne viruses among Australian prison entrants.
  Crofts N, Stewart T, Hearne P, Ping XY, Breshkin AM, Locarnini SA
  BMJ. 1995 Feb; 310(6975):285-288
• Hepatitis-B Vaccination - What are the current international recommedations?
  Thompson SC, Ruff TA
  Clin Immunother. 1995 Feb; 3(1):15-26
• Disseminated histoplasmosis: successful maintenance therapy with oral fluconazole.
  Lewin SR, Street AC
  Aust N Z J Med. 1995 Feb; 25(1):56
• Comparative studies of the major xenoantigen gal alpha(1,3)gal in pigs and mice.
  McKenzie IF, Koulmanda M, Mandel T, Xing PX, Sandrin MS
  Transplant Proc. 1995 Feb; 27(1):247-248
• Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia.
  Ruff TA, Gertig DM, Otto BF, Gust ID, Sutanto A, Soewarso TI, Kandun N, Marschner IC, Maynard JE
  J Infect Dis. 1995 Feb; 171(2):290-296
• The natural killer cell serine protease gene Lmet1 maps to mouse chromosome 10.
  Thia KY, Jenkins NA, Gilbert DJ, Copeland NG, Smyth MJ
  Immunogenetics. 1995 Feb; 41(1):47-49
• Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.
  Poumbourios P, el Ahmar W, McPhee DA, Kemp BE
  J Virol. 1995 Feb; 69(2):1209-1218
• Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid.
  Wang Y, Luscombe , Bowden S, Shaw T, Locarnini S
  Antimicrob Agents Chemother. 1995 Feb; 39(2):556-558
• In vitro growth of the microsporidian Septata intestinalis from an AIDS patient with disseminated illness.
  Doultree JC, Maerz AL, Ryan NJ, Baird RW, Wright E, Crowe SM, Marshall JA
  J Clin Microbiol. 1995 Feb; 33(2):463-470

January, 1995 (7)

• Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose alpha(1-3)galactose reactive lectin.
  Vaughan HA, McKenzie IF, Sandrin MS
  Transplantation. 1995 Jan; 59(1):102-109
• A simple method for the propagation of cervical lymphocytes.
  Moscicki AB, Hunter SD, Garland S, Quinn M, Crowe SM, Shortman K, Stites D
  Clin Diagn Lab Immunol. 1995 Jan; 2(1):40-43
• Preferential entry and productive infection of CD4 expressing lymphoid dendritic cells by macrophage-tropic HIV-1.
  P U Cameron, M G Lowe, F Sotzik, A F Coughlan, S M Crowe, K Shortman
  Adv Exp Med Biol. 1995 Jan; 378:429-433
• The closely linked genes encoding the myeloid nuclear differentiation antigen (MNDA) and IFI16 exhibit contrasting haemopoietic expression.
  Dawson MJ, Trapani JA, Briggs RC, Nicholl JK, Sutherland GR, Baker E
  Immunogenetics. 1995 Jan; 41(1):40-43
• IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
  Dawson MJ, Trapani JA
  J Cell Biochem. 1995 Jan; 57(1):39-51
• Distinct granzyme expression in human CD3- CD56+ large granular- and CD3- CD56+ small high density-lymphocytes displaying non-MHC-restricted cytolytic activity.
  Smyth MJ, Browne KA, Kinnear BF, Trapani JA, Warren HS
  J Leukoc Biol. 1995 Jan; 57(1):88-93
• Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.
  Brown LE, White DO, Agius C, Kemp BE, Yatzakis N, Poumbourios P, McPhee DA, Jackson DC
  Arch Virol. 1995 Jan; 140(4):635-654